Search clinical trials for: Capecitabine (Xeloda®)

Total 15666 results

Brian Czito
Amgen

Completed

Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer (POXX)

Cancer of the Esophagus

United States
M.D. Anderson Cancer Center

Withdrawn

Proton Therapy With Capecitabine for Rectal Cancer

Rectal Cancer
The University of Hong Kong

Completed

Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC)

Carcinoma, Hepatocellular | Secondary

Hong Kong
Chinese PLA General Hospital

Unknown

T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy

Gastric Cancer

China
King Faisal Specialist Hospital & Research Center

Unknown

Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer

Rectal Adenocarcinoma

Saudi Arabia
M.D. Anderson Cancer Center
Novartis Pharmaceuticals

Terminated

Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma

Solid Tumor | Thyroid Cancer

United States
National Cancer Institute (NCI)

Terminated

Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer

Liver Metastases | Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer

United States
University of Virginia
Syndax Pharmaceuticals

Completed

A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy (Breast49)

Breast Cancer | Metastatic Breast Cancer

United States
NYU Langone Health
Bristol-Myers Squibb; Eli Lilly and Company

Completed

Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer

Neoplasm Metastasis | Colorectal Cancer

United States
Osama Rahma, MD
Merck Sharp & Dohme LLC; Hoosier Cancer Research Network

Withdrawn

Trial of Chemoradiation and Pembrolizumab in Patients With Rectal Cancer

Rectal Cancer | Rectal Neoplasm
H. Lee Moffitt Cancer Center and Research Institute
Roche Pharma AG

Terminated

Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)

Adenocarcinoma | Colon Cancer

United States
Merck Sharp & Dohme LLC

Not yet recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR

Triple-Negative Breast Cancer
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche

Completed

Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy

Rectal Cancer

Austria
LI XIN-XIANG

Recruiting

Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy

Rectal Neoplasms

China
Memorial Sloan Kettering Cancer Center
University of Colorado, Denver; Washington University School of Medicine; University... and other collaborators

Active, not recruiting

Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management

Rectal Cancer

United States
Merck Sharp & Dohme LLC

Recruiting

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Breast Neoplasms

Israel, United States, Taiwan, Hong Kong, Korea, Republic of, Switzerland
University of Miami

Completed

Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer

Pancreatic Cancer

United States
The University of Hong Kong

Completed

Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic Adenocarcinoma

Pancreatic Adenocarcinoma

Hong Kong
Hoffmann-La Roche

Completed

A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver Cancer

Carcinoma, Hepatocellular

China, Thailand, Taiwan
Arbeitsgemeinschaft medikamentoese Tumortherapie

Completed

Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer (MBC-6)

Breast Cancer

Austria
The University of Hong Kong

Completed

Study of Xeloxiri Regimen for Patients With Refractory Metastatic Colorectal Cancer

Colorectal Cancer

Hong Kong
Sun Yat-sen University

Completed

Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

China
Fudan University

Unknown

A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGC

Gastric Cancer

China
Fudan University

Unknown

Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer

Rectal Cancer

China
Academisch Medisch Centrum - Universiteit van Amsterdam...

Unknown

Everolimus and Capecitabine in Patients With Advanced Malignancy (m-TOR)

Advanced Malignancies

Netherlands
Kidney Cancer Research Bureau

Recruiting

Nivolumab in Combination With Chemotherapy for FGFR2-positive Metastatic Gastric Cancer (NIVOFGFR2)

Metastatic Gastric Cancer | FGFR2 Amplification | PD-L1 Gene Amplification

United States
Heikki Joensuu

Terminated

Effects of S-1 and Capecitabine on Coronary Artery Blood Flow (FluoHeart)

Stomach Cancer | Small Bowel Cancer | Colon Cancer | Esophagus Cancer | Rectum Cancer

Finland
Hoffmann-La Roche

Completed

A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer (JOSHUA)

Gastric Cancer

France, Belgium, Korea, Republic of, Spain, Czechia, Germany, Italy, Netherlands
National Cancer Institute (NCI)

Completed

S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer

Breast Cancer
Sun Yat-sen University

Completed

A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer

HER2 Positive Breast Cancer

China
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma

Gallbladder Cancer | Extrahepatic Bile Duct Cancer

United States
National Cancer Institute (NCI)

Completed

GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific | Stage IIIC Rectal Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal Cancer

United States
Hoffmann-La Roche

Completed

A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer

Breast Cancer

France, Spain, Sweden, Russian Federation, Denmark, Slovakia
Shanghai Zhongshan Hospital

Unknown

Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma

Cholangiocarcinoma

China
Sponsor GmbH
GlaxoSmithKline; iOMEDICO AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis Klinische Studien

Terminated

Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer (CELAVIE)

Metastatic Breast Cancer | HER2 Positive | First or Second Line Therapy | Failure or Contraindication of Trastuzumab Therapy

Germany
AHS Cancer Control Alberta

Unknown

Oxaliplatin Pharmacokinetics With and Without Ca2+/MG2+ Infusion in Colorectal Cancer Patients

Colorectal Cancer | Colorectal Carcinoma | Neoplasms, Colorectal

Canada
Weill Medical College of Cornell University
Celgene Corporation

Completed

Epigenetic Priming Using Azacitidine With Neoadjuvant Chemotherapy for Resectable Esophageal Cancer (VEOX)

Esophageal Cancer | Malignant Neoplasm of Cardio-esophageal Junction of Stomach

United States
Pamela L. Kunz
Genentech, Inc.

Completed

Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma

Stomach Cancer | Gastrointestinal Stromal Tumor (GIST) | Gastric (Stomach) Cancer | Neoplasm of Cardioesophageal Junction

United States
Hoffmann-La Roche

Completed

A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal Cancer

Colorectal Cancer

Taiwan
Accelerated Community Oncology Research Network
Hoffmann-La Roche; AstraZeneca

Completed

Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Pfizer

Completed

A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together

Neoplasms | Breast Cancer | Solid Tumors

United States
Dutch Colorectal Cancer Group
Sanofi; Roche Pharma AG; Koningin Wilhelmina Fonds; Immunicon

Completed

Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer

Colorectal Cancer

Netherlands
Hebei Medical University

Unknown

Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver Metastasis

Gastric Cancer | Liver Metastasis

China
Gilead Sciences
Alliance Foundation Trials, LLC.; NSABP Foundation Inc

Recruiting

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/NSABP B-63) (ASCENT-05)

Triple Negative Breast Cancer

United States
Peking Union Medical College Hospital

Not yet recruiting

TIME in Immunotherapy Combined With nCRT for Rectal Cancer (TIMENT-R)

Locally Advanced Rectal Cancer
Merck Sharp & Dohme LLC

Completed

SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716)

Breast Neoplasms | Carcinoma, Non-Small-Cell Lung
Jeroen Bosch Ziekenhuis
Eindhoven Cancer Registry

Completed

A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer (DoCCS)

Gastric Cancer

Netherlands
Washington University School of Medicine

Completed

Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer

Colorectal Neoplasms

United States
Rabin Medical Center

Unknown

Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric Cancer

Advanced Gastric Cancer

Israel
Fifth Affiliated Hospital, Sun Yat-Sen University

Recruiting

Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Capecitabine | Radiotherapy | PD-1 Inhibitor

China

3

Subscribe